Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil is a promising, safe treatment for various hair diseases, improving hair thickness and density, but more research is needed on long-term side effects and treatment duration.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

A quick method to measure minoxidil using a light-based titration technique was developed.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

QLT0267 stops hair follicle cell growth and movement.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Low-level laser or light devices could be a cheaper, side-effect free treatment for hair loss, but more research is needed to confirm their effectiveness.

LPA 4 helps control blood and lymph vessel development in zebrafish.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

Low-dose oral minoxidil effectively treats female hair loss with good safety.

Low-dose oral minoxidil may be effective for hair loss treatment.

LLLT devices for hair loss need more research to define proper guidelines.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

A genetic variant in the KRT71 gene may cause loose anagen hair and wooly hair, and symptoms might improve with age.

The LAMTOR3 gene is involved in cashmere goat hair growth and is affected by certain treatments and other genes.

Tumescent local anesthesia is a safe, cost-effective method for outpatient liposuction.

Loricrin affects skin immune function and homeostasis.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

QMSI is a valuable method for studying drug penetration in skin tissues.

The document cannot be understood or processed.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

A new accurate method was developed to measure Minoxidil and Aminexil in solutions.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Quality control and assurance are crucial for improving hair transplant surgery outcomes.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

One twin girl has Loose anagen syndrome with poorly anchored hair, diagnosed with a simple hair pull test, while her identical twin does not have the condition.